B. Riley Securities maintains Buy on Enovix, cuts price target to $9

scanx
Reviewed by
Ritika DScanX News Team
Key Highlights

B. Riley Securities analyst Ryan Pfingst maintains a Buy rating on Enovix (ENVX) but reduces the price target from $10 to $9. The firm retains its positive outlook on the stock while adjusting its valuation expectations downward by $1.

powered bylight_fuzz_icon
48177931

*this image is generated using AI for illustrative purposes only.

B. Riley Securities has maintained its Buy rating on Enovix (NASDAQ: ENVX) while lowering its price target from $10 to $9. Analyst Ryan Pfingst issued the update, signaling continued confidence in the company's long-term prospects despite the reduced near-term valuation ceiling.

The revised target represents a $1 decrease from the previous estimate. The firm did not disclose specific operational metrics or financial results driving this adjustment in the provided data.

Analyst Action

Metric Previous Current
Rating Buy Buy
Price Target $10 $9

The maintenance of the Buy rating suggests that B. Riley Securities still views Enovix as an attractive investment opportunity relative to its peers or intrinsic value, albeit at a lower expected return than previously modeled.

What specific operational or market factors prompted B. Riley Securities to lower the price target while maintaining a Buy rating?

How does Enovix's current valuation compare to its peers in the advanced battery technology sector following this adjustment?

What are Enovix's upcoming catalysts, such as production milestones or new partnerships, that could justify a future price target increase?

like17
dislike

Cantor Fitzgerald maintains $25 target on Enovix stock

scanx
Reviewed by
Ritika DScanX News Team
Key Highlights

Cantor Fitzgerald analyst Derek Soderberg reaffirmed an Overweight rating on Enovix (ENVX). The brokerage kept its price target at $25, indicating steady sentiment towards the battery technology company without adjusting its valuation outlook.

powered bylight_fuzz_icon
48172863

*this image is generated using AI for illustrative purposes only.

Cantor Fitzgerald analyst Derek Soderberg reiterated an Overweight rating on Enovix (NASDAQ: ENVX) and maintained a $25 price target for the company.

The research note reflects the firm's continued stance on the silicon-anode battery developer.

Analyst Action

Metric Detail
Rating Overweight
Price Target $25
Analyst Derek Soderberg

Soderberg’s update confirms no change to the previous valuation framework for Enovix. The firm did not disclose specific operational metrics or earnings estimates in this brief update.

How might Enovix's recent progress in silicon-anode battery manufacturing scale impact its ability to meet the $25 price target within the current fiscal year?

What are the key competitive threats from traditional lithium-ion battery manufacturers that could challenge Enovix's market share in the consumer electronics sector?

Could potential partnerships with major smartphone or automotive OEMs serve as a catalyst for Enovix to exceed Cantor Fitzgerald's current valuation framework?

like18
dislike

More News on Enovix Corp